Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1997-10-09
1999-11-09
Campbell, Bruce R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
424 141, 424 145, 424 149, 424 169, A61K 4800
Patent
active
059815043
ABSTRACT:
The present invention provides a method to achieve radioisotopic localization at tumor sites, i.e., a method of enhancing radiolabeled ligand localization to a tumor in an individual in need of such treatment, comprising the steps of: transducing said tumor with a gene encoding a membrane expressed protein unique to said tumor; and administering to said individual a radiolabeled ligand which specifically binds to said protein. The use of gene therapy technology to induce expression of high affinity membrane molecules/receptors can enhance the specificity of radioisotope localization while the use of radioactive isotopes with the ability to deliver radiation damage across several cell diameters will compensate for less than perfect transduction efficiency.
REFERENCES:
Raben et al (1996) Gene Therapy 3:567-580.
Buchsbaum Donald J.
Curiel David T.
Khazaeli Mohammad B.
Raben David
Stackhouse Murray
Adler Benjamin Aaron
Campbell Bruce R.
UAB Research Foundation
LandOfFree
Genetic induction of receptors for targeted radiotherapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genetic induction of receptors for targeted radiotherapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetic induction of receptors for targeted radiotherapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1456075